CJC-1295 (With DAC) Peptide

What is CJC-1295 (With DAC)?

A synthetic analogue of growth hormone-releasing hormone (GHRH), CJC-1295 (With DAC) significantly increases plasma levels of growth hormone (GH) and insulin-like growth factor 1 (IGF-1). The addition of DAC (Drug Affinity Complex) extends its half-life, enhancing duration and efficacy.

Key Properties:

• Boosts GH and IGF-1 Levels: Elevates plasma growth hormone and insulin-like growth factor 1, promoting muscle growth and repair.
• Extended Duration: DAC prolongs action, reducing the need for frequent dosing.
• Supports Muscle Growth and Fat Loss: Increased GH and IGF-1 levels aid in muscle development and fat reduction.
• Improves Recovery: Enhances the body's healing processes for quicker recovery.
• Synergistic Effects with Ipamorelin: When paired with Ipamorelin, a GH secretagogue, it exhibits enhanced efficacy, leading to more significant results in GH release without increasing side effects.

Research Use:

Studied for its potential in GH therapy, CJC-1295 (With DAC) offers a promising approach to muscle growth, recovery, and metabolic health, with synergistic benefits when combined with Ipamorelin.

Detailed Description

CJC-1295 with DAC is a modified GHRH with an added Drug Affinity Complex, boosting its longevity in the bloodstream for sustained GH release. This leads to enhanced GH and IGF-1 levels, supporting muscle and skeletal growth, fat loss, and recovery. The DAC component allows for less frequent dosing while maintaining consistent hormone levels. Particularly when used in conjunction with Ipamorelin, CJC-1295 with DAC maximizes growth hormone stimulation efficiently, providing a synergistic effect that enhances the benefits of GH therapy without exacerbating side effects.